Corebridge Financial (CRBG) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Achieved 17% year-over-year growth in premiums and deposits to $11.7 billion, with operating EPS up 9% to $1.13 and adjusted ROAE at 12.0%.
Net income for Q2 2024 was $365 million, down from $771 million in Q2 2023, mainly due to higher realized losses.
Returned $575 million to shareholders in Q2, with $961 million returned year-to-date and a 70% payout ratio.
Completed sale of UK life business in April 2024, generating a $246 million pre-tax gain; proceeds to be returned via share repurchase.
Welcoming Nippon Life as a shareholder pending regulatory approval, with transaction expected to close in Q1 2025.
Financial highlights
Adjusted pre-tax operating income (APTOI) for Q2 2024 was $859 million, up from $836 million in Q2 2023.
Net investment income rose to $3.0 billion, up 10% year-over-year; base yield improved to 4.82%.
Assets under management and administration reached $394 billion, up 6% year-over-year.
Book value per share was $18.32; adjusted book value per share was $37.95 at June 30, 2024.
Aggregate core sources of income grew 5% year-over-year, with fee income up 8% and underwriting margin up 4%.
Outlook and guidance
Expect continued growth in earnings and cash flows, supported by demographic trends and higher interest rates.
Ongoing focus on capital optimization, including further Bermuda reinsurance and efficiency levers.
Payout ratio target of 60%-65% for 2024, with UK sale proceeds as additional distribution.
Expense reduction targeted at $400 million in annual run-rate savings through Corebridge Forward initiative.
Anticipate marginal spread compression but continued growth in base spread income.
Latest events from Corebridge Financial
- Record sales, robust capital return, and reduced risk support a strong 2026 outlook.CRBG
Q4 202510 Feb 2026 - Strong growth, disciplined capital management, and product innovation drive long-term value.CRBG
Barclays 23rd Annual Global Financial Services Conference21 Jan 2026 - Adjusted operating income up 27% year-over-year despite a $1.2B net loss.CRBG
Q3 202416 Jan 2026 - 2024 EPS up 18%, $2.3B returned to shareholders, and strong segment growth achieved.CRBG
Q4 20248 Jan 2026 - Delivering on growth, efficiency, and capital return targets while expanding product and distribution.CRBG
KBW Insurance Conference 20255 Jan 2026 - Exceeded 2024 targets, strengthened governance, and enhanced shareholder rights and compensation practices.CRBG
Proxy Filing2 Dec 2025 - Stockholders will vote on charter amendments for Board by-law authority and written consent rights.CRBG
Proxy Filing2 Dec 2025 - Stockholders will vote on Board by-law authority and a 25% threshold for written consent action.CRBG
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.CRBG
Proxy Filing2 Dec 2025